NRIX·67080M103·US·equity·Healthcare - Biotechnology-13D/G
NRIX (NURIX THERAPEUTICS INC) is held by 104 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($138.3M), FMR LLC ($85.9M), STATE STREET CORP ($79.7M). Net institutional sentiment: Mixed.
See how NRIX's score breaks down across 4 SEC sources
Showing 1-20 of 115
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer